Investment in the country
Our commitment to local manufacturing
The manufacturing site was established in 1972, it is strategically place in Pretoria. The site is EU (AIFA) and ANVISA approved and is a Global center of excellence in the production of TB products for the SA and Global markets. The continues investment at our local manufacturing site is aligned to the government’s planned National Industrial Policy, where the pharmaceutical sector has been identified as a lead sector for economic growth – including the Industrial Policy Action Plan (IPAP2).
The factory expansions have resulted in Sanofi being able to create employment opportunities for the South African people (approximately 300 employees and contractors). Sanofi manufacturing site is the leading producer of TB and Epilim disease medicines in South Africa. Previous big investment include creation of TB facility to export to the European market, build Epilim facility and transfer of Epilim manufacturing from United Kingdom to Waltloo to reduce cost of product for the South African patient.